UBS Group’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128 | Buy |
1,500
+468
| +45% | +$40 | ﹤0.01% | 8651 |
|
|
2025
Q1 | $73 | Sell |
1,032
-2,879
| -74% | -$204 | ﹤0.01% | 8665 |
|
|
2024
Q4 | $501 | Sell |
3,911
-11,340
| -74% | -$1.45K | ﹤0.01% | 8197 |
|
|
2024
Q3 | $686 | Sell |
15,251
-8,230
| -35% | -$370 | ﹤0.01% | 7629 |
|
|
2024
Q2 | $1.41K | Buy |
23,481
+23,412
| +33,930% | +$1.41K | ﹤0.01% | 7416 |
|
|
2024
Q1 | $13 | Buy |
+69
| New | +$13 | ﹤0.01% | 7895 |
|
|
2023
Q4 | – | Sell |
-7,812
| Closed | -$625 | – | 8413 |
|
|
2023
Q3 | $625 | Buy |
+7,812
| New | +$625 | ﹤0.01% | 7220 |
|
|
2023
Q2 | – | Sell |
-3,356
| Closed | -$604 | – | 8217 |
|
|
2023
Q1 | $604 | Buy |
+3,356
| New | +$604 | ﹤0.01% | 7857 |
|
|
2022
Q3 | – | Sell |
-186
| Closed | – | – | 9524 |
|
|
2022
Q2 | $0 | Buy |
+186
| New | – | ﹤0.01% | 9560 |
|
|
2022
Q1 | – | Sell |
-4,358
| Closed | -$8K | – | 9458 |
|
|
2021
Q4 | $8K | Buy |
4,358
+1,985
| +84% | +$3.64K | ﹤0.01% | 7922 |
|
|
2021
Q3 | $11K | Buy |
+2,373
| New | +$11K | ﹤0.01% | 6751 |
|
|
2020
Q4 | – | Sell |
-3,475
| Closed | -$1K | – | 7530 |
|
|
2020
Q3 | $1K | Buy |
+3,475
| New | +$1K | ﹤0.01% | 6928 |
|
|
2020
Q2 | – | Sell |
-6,100
| Closed | – | – | 7230 |
|
|
2020
Q1 | $0 | Buy |
6,100
+500
| +9% | – | ﹤0.01% | 7142 |
|
|
2019
Q4 | $1K | Buy |
5,600
+500
| +10% | +$89 | ﹤0.01% | 6883 |
|
|
2019
Q3 | $1K | Hold |
5,100
| – | – | ﹤0.01% | 6874 |
|
|
2019
Q2 | $1K | Hold |
5,100
| – | – | ﹤0.01% | 6846 |
|
|
2019
Q1 | $1K | Hold |
5,100
| – | – | ﹤0.01% | 6713 |
|
|
2018
Q4 | $2K | Buy |
+5,100
| New | +$2K | ﹤0.01% | 6868 |
|
|
2018
Q3 | – | Sell |
-800
| Closed | – | – | 7117 |
|
|
2018
Q2 | $0 | Buy |
+800
| New | – | ﹤0.01% | 7109 |
|
|
2018
Q1 | – | Sell |
-995
| Closed | – | – | 7003 |
|
|
2017
Q4 | $0 | Buy |
+995
| New | – | ﹤0.01% | 6929 |
|